Skip to main content

AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE

Suspended · Not applicable · NCT06174805

Conditions: Gastric Outlet Obstruction

At a glance

Research payments reported, 2025
$238,392
U.S. investigators named
5
Sites paid
10
Planned or actual enrollment
67

About the trial

Sponsor
Boston Scientific Corporation
Tested
AXIOS(TM) Stent and Electrocautery Enhanced Delivery System (device)
Dates
Started 2025-02-11; completion 2027-09
Results posted
Not yet

To investigate the safety and technical success of EUS-guided gastroenterostomy (EUS-GE) using the AXIOSTM lumen-apposing Metal Stent for the management of symptoms associated with gastric outlet obstruction from malignant unresectable neoplasm.

From ClinicalTrials.gov, last updated 2026-11-04. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Boston Scientific Corporation reported $238,392 in research payments for this study in 2025 (46 payments).

Products named: Clinical Trial Product

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Mayo Clinic Jacksonville $85,193
  • Brigham and Women's Hospital, MA $51,544
  • University of Pittsbugh Physicians $22,286
  • Weill Medical College of Cornell $18,750
  • Benaroya Research Institute at Virginia Mason $17,411
  • Mayo Clinic $15,445
  • New York Presbyterian Weill Cornell Medical Center $6,941
  • Brigham and Womens Hospital $6,941
  • Pulmonary Consultants-University of Pittsburg Medical Center $6,941
  • Virginia Mason Medical Center $6,941

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.